← Back to Screener
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)
Price$9.68
Favorite Metrics
Price vs S&P 500 (26W)-5.11%
Price vs S&P 500 (4W)-14.74%
Market Capitalization$43.20B
P/E Ratio (Annual)19.16x
Indicated Dividend Yield (Annual)1.99%
All Metrics
P/CF (Annual)12.13x
Book Value / Share (Quarterly)$2.49
Indicated Dividend (Annual)$9.20
Revenue Growth (3Y)0.53%
Cash Flow / Share (Quarterly)$0.34
Payout Ratio (TTM)36.71%
Price vs S&P 500 (YTD)-8.26%
Gross Margin (TTM)64.69%
Net Profit Margin (TTM)15.11%
EPS (TTM)$0.25
10-Day Avg Trading Volume14.75M
EPS Excl Extra (TTM)$0.25
Revenue Growth (5Y)2.20%
EPS (Annual)$0.25
Dividend / Share (Annual)$0.09
ROI (Annual)6.66%
Gross Margin (Annual)65.01%
Net Profit Margin (5Y Avg)12.31%
Cash / Share (Quarterly)$0.20
P/E Basic Excl Extra (TTM)19.16x
Revenue Growth QoQ (YoY)101.16%
EPS Growth (5Y)8.30%
P/E Normalized (Annual)19.16x
ROA (Last FY)5.11%
Revenue Growth TTM (YoY)-1.81%
EBITD / Share (TTM)$0.40
ROE (5Y Avg)7.43%
Operating Margin (TTM)21.87%
Cash Flow / Share (Annual)$0.34
P/B Ratio1.94x
P/B Ratio (Quarterly)2.03x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)3.56x
Net Interest Coverage (TTM)8.29x
ROA (TTM)5.17%
EPS Growth QoQ (YoY)280.16%
EV / EBITDA (TTM)14.79x
EPS Incl Extra (Annual)$0.25
Current Ratio (Annual)0.92x
Quick Ratio (Quarterly)0.71x
3-Month Avg Trading Volume13.34M
52-Week Price Return-7.87%
EV / Free Cash Flow (Annual)17.66x
P/E Incl Extra (TTM)19.16x
Revenue / Employee (TTM)$1
P/S Ratio (Annual)2.90x
Asset Turnover (Annual)0.34x
52-Week High$419.40
Operating Margin (5Y Avg)18.58%
EPS Excl Extra (Annual)$0.25
CapEx CAGR (5Y)5.37%
26-Week Price Return3.64%
Quick Ratio (Annual)0.69x
13-Week Price Return-2.17%
Total Debt / Equity (Annual)0.52x
Current Ratio (Quarterly)0.92x
Enterprise Value$53,047.936
Revenue / Share Growth (5Y)2.67%
Asset Turnover (TTM)0.34x
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)3.48x
Pretax Margin (Annual)19.51%
Cash / Share (Annual)$0.19
3-Month Return Std Dev27.16%
Gross Margin (5Y Avg)62.95%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)6.41%
ROE (Last FY)10.15%
Net Interest Coverage (Annual)9.28x
EPS Basic Excl Extra (Annual)$0.25
P/FCF (TTM)14.38x
EV / Free Cash Flow (TTM)17.66x
Total Debt / Equity (Quarterly)0.52x
EPS Incl Extra (TTM)$0.25
Receivables Turnover (Annual)6.83x
ROI (TTM)6.74%
P/S Ratio (TTM)2.90x
Pretax Margin (5Y Avg)16.59%
Revenue / Share (Annual)$1.65
Tangible BV / Share (Annual)$-1.77
Forward P/E17.28x
Free OCF CAGR (5Y)15.32%
Price vs S&P 500 (52W)-42.96%
P/E Ratio (TTM)19.16x
EPS Growth TTM (YoY)17.57%
Year-to-Date Return-5.02%
5-Day Price Return-0.34%
EPS Normalized (Annual)$0.25
ROA (5Y Avg)3.89%
Net Profit Margin (Annual)15.11%
Month-to-Date Return-4.76%
Cash Flow / Share (TTM)$0.06
EBITD / Share (Annual)$0.38
EPS Growth (3Y)17.21%
Operating Margin (Annual)22.32%
LT Debt / Equity (Annual)0.47x
P/CF (TTM)12.13x
ROI (5Y Avg)5.04%
P/E Excl Extra (TTM)19.16x
LT Debt / Equity (Quarterly)0.47x
EPS Basic Excl Extra (TTM)$0.25
Payout Ratio (Annual)36.71%
P/B Ratio (Annual)2.03x
Dividend / Share (TTM)$0.09
Inventory Turnover (TTM)3.52x
Pretax Margin (TTM)19.51%
Book Value / Share (Annual)$2.49
Price vs S&P 500 (13W)-5.04%
Net Margin Growth (5Y)5.47%
Dividend Yield (TTM)1.92%
Beta0.42x
P/FCF (Annual)14.38x
Revenue / Share (TTM)$1.66
ROE (TTM)10.30%
52-Week Low$325.10
Industry Peers — Cosmetics & Toiletries(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares) | 2.90x | -1.81% | 64.69% | 8.30% | $9.68 |
CLColgate-Palmolive Company | 3.29x | 1.40% | 60.11% | -3.48% | $83.53 |
KVUEKenvue Inc. | 2.23x | -2.14% | 58.62% | — | $17.58 |
ELThe Estee Lauder Companies Inc. Class A | 1.89x | -3.35% | 74.33% | — | $77.85 |
ELFe.l.f. Beauty, Inc. | 2.66x | 16.73% | 70.27% | 40.38% | $68.42 |
IPARInterparfums, Inc. Common Stock | 2.12x | 2.49% | 55.46% | 34.17% | $98.01 |
COTYCOTY INC | 1.74x | 9.07% | 63.93% | — | $2.37 |
OLPXOlaplex Holdings, Inc. Common Stock | 3.21x | 0.07% | 70.75% | -20.80% | $2.04 |
EPCEdgewell Personal Care Company | 0.51x | -3.36% | 41.52% | -15.49% | $23.57 |
WALDWaldencast plc Class A Ordinary Share | 0.33x | -0.27% | 68.13% | — | $1.03 |
SLSNSolesence, Inc. Common Stock | 1.42x | 18.56% | 25.88% | -0.79% | $1.22 |
About
Haleon is a leading global consumer health company operating across oral care, digestive health, pain relief, and nutrition. The company generates 60% of revenue from global power brands—Sensodyne, Advil, Centrum, and Poligrip—which hold leading positions in their categories, supplemented by regional brands including Emergen-C, Eno, Tums, and Caltrate. Formed by combining consumer health divisions from GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022.